These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19132241)

  • 1. Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function.
    Gori AM; Marcucci R; Paniccia R; Giusti B; Fedi S; Antonucci E; Buonamici P; Antoniucci D; Gensini GF; Abbate R
    Thromb Haemost; 2008 Dec; 100(6):1136-45. PubMed ID: 19132241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting thrombotic events: creating a complex approach for a complex condition.
    Shantsila E; Lip GY
    Thromb Haemost; 2008 Dec; 100(6):962-4. PubMed ID: 19132217
    [No Abstract]   [Full Text] [Related]  

  • 3. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel discontinuation and platelet reactivity following coronary stenting.
    Mylotte D; Peace AJ; Tedesco AT; Mangiacapra F; Dicker P; Kenny D; Foley DP
    J Thromb Haemost; 2011 Jan; 9(1):24-32. PubMed ID: 20961396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis.
    Blindt R; Stellbrink K; de Taeye A; Müller R; Kiefer P; Yagmur E; Weber C; Kelm M; Hoffmann R
    Thromb Haemost; 2007 Dec; 98(6):1329-34. PubMed ID: 18064332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
    Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
    Sibbing D; Morath T; Braun S; Stegherr J; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2010 Jan; 103(1):151-9. PubMed ID: 20062919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
    Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.
    Siller-Matula JM; Christ G; Lang IM; Delle-Karth G; Huber K; Jilma B
    J Thromb Haemost; 2010 Feb; 8(2):351-9. PubMed ID: 19943879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.
    Behr T; Kuch B; Behr W; von Scheidt W
    Clin Res Cardiol; 2011 Oct; 100(10):907-14. PubMed ID: 21533581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
    Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy.
    Marcucci R; Gori AM; Paniccia R; Giglioli C; Buonamici P; Antoniucci D; Gensini GF; Abbate R
    Atherosclerosis; 2007 Nov; 195(1):e217-23. PubMed ID: 17555759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.
    Sibbing D; Schulz S; Braun S; Morath T; Stegherr J; Mehilli J; Schömig A; von Beckerath N; Kastrati A
    J Thromb Haemost; 2010 Feb; 8(2):250-6. PubMed ID: 19943882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
    Saunders J; Nambi V; Kimball KT; Virani SS; Morrisett JD; Lumsden AB; Ballantyne CM; Dong JF;
    J Vasc Surg; 2011 Mar; 53(3):668-75. PubMed ID: 21227624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the laboratory in monitoring patients receiving dual antiplatelet therapy.
    Vidali M; Rolla R; Parrella M; Cassani C; Manzini M; Portalupi MR; Serino R; Prando MD; Bellomo G; Pergolini P
    Int J Lab Hematol; 2012 Oct; 34(5):484-94. PubMed ID: 22613071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
    Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
    Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.
    Tsantes A; Ikonomidis I; Papadakis I; Kottaridi C; Tsante A; Kalamara E; Kardoulaki A; Kopterides P; Kapsimali V; Karakitsos P; Lekakis J; Travlou A
    Platelets; 2012; 23(6):481-9. PubMed ID: 22646492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.